Pre-Emption Battle Looms In Supreme Court As FDA Finalizes Labeling Rule

FDA's final rule on sponsors' obligations to update their labels alters the definition of "newly acquired information" from the proposed rule while leaving the remainder intact. The change could be a boon to industry, but a slap to Democrats who had called for the rule's withdrawal